On November 10, 2020 Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) ("Innate" or the "Company"), reported that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences (Press release, Innate Pharma, NOV 10, 2020, View Source [SID1234570700]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bryan Garnier & Co Virtual European Healthcare Conference
Date: November 17, 2020
Fireside Chat: November 17, 2020 at 10:00 a.m. CET

Jefferies Virtual London Healthcare Conference
Date: November 18, 2020

SVB Leerink Oncology 1×1 Day
Date: November 19, 2020

Oddo – Tech40 Digital Forum 5th Edition
Date: November 24-25, 2020

Evercore ISI 3rd Annual HealthCONx
Date: December 1-3, 2020
Fireside Chat: December 2, 2020 at 8:50-9:10 a.m. ET

A replay of Innate’s presentation at the Bryan Garnier conference and a live webcast of Innate’s presentation at the Evercore ISI conference will be accessible through the News & Events page of the Investors section of the Company’s website at www.innate-pharma.com.